IPC-klasse
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.04.28, US 125835 P
2008.05.09, US 127044 P
BONITO A: "Effect of hyaluronidase administration on glycemic curves due to insulin in normal and diabetic subjects" MINERVA MEDICA, EDIZIONI MINERVA MEDICA, TORINO, IT, vol. 45, no. 31, 18 April 1954 (1954-04-18), pages 1068-1073, XP009124588 ISSN: 0026-4806 (B1)
WO-A-2009/047766 (B1)
CA-A1- 1 243 948 (B1)
DATABASE ADISCTI [Online] 9 October 2008 (2008-10-09), YOCUM R C ET AL: "Pharmacokientics and glucodynamics of an insulin analog injected with recombinant human hyaluronidase: fast-acting insulin analog made faster. ADIS TITLE: Insulin lispro +/- hyaluronidase: pharmacokinetics In volunteers" XP002552072 retrieved from STN Database accession no. 2008:35541 & 68TH ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION LATE BREAKERS, MEETING INFO: ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (68TH ) SAN FRANCISCO, CA, USA), June 2008 (2008-06), (B1)
DATABASE IMSDRUGNEWS [Online] 2008, ANONYMOUS: "rHuPH20 Halozyme phase change II USA (diabetes)" XP002552071 retrieved from STN Database accession no. 2008:5917 & R & D FOCUS DRUG NEWS, 10 November 2008 (2008-11-10), (B1)
EP-A- 1 048 264 (B1)
HALLER M F: "Converting intravenous dosing to subcutaneous dosing: With recombinant human hyaluronidase" PHARMACEUTICAL TECHNOLOGY, ADVANSTAR COMMUNICATIONS,INC, US, vol. 31, no. 12, 1 December 2007 (2007-12-01), page 118,120,122,124,126,128,130,132, XP009122858 ISSN: 1543-2521 (B1)
HELLER ET AL: "Insulin's 85th anniversary-An enduring medical miracle" DIABETES RESEARCH AND CLINICAL PRACTICE, AMSTERDAM, NL, vol. 78, no. 2, 26 September 2007 (2007-09-26), pages 149-158, XP022272030 ISSN: 0168-8227 (B1)
HOLDEN J C ET AL: "Use of hyaluronidase in insulin coma therapy" BRITISH MEDICAL JOURNAL, LONDON, GB, vol. 2, no. 5036, 13 July 1957 (1957-07-13), pages 85-86, XP009124578 ISSN: 0267-0623 (B1)
JOST F: "Zur Insulinempfindlichkeit der Schizophrenen, Insulineinsparung durch Hyaluronidase = Insulin sensitivity in schizophrenia; insulin economy with hyaluronidase" WIENER KLINISCHE WOCHENSCHRIFT, NEW YORK, NY, US, vol. 70, no. 36, 5 September 1958 (1958-09-05), pages 657-661, XP009124581 ISSN: 0043-5325 (B1)
KEUP W: "Amorphes Insulin und Hyaluronidase in der Insulinbehandlung der Psychosen // Amorphous insulin & hyaluronidase in insulin treatment of psychoses" SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, SCHWABE, BASEL, CH, vol. 87, no. 35-36, 31 August 1957 (1957-08-31), pages 1128-1131, XP009124579 ISSN: 0036-7672 (B1)
PIRRELLO ROSENE D ET AL: "Initial experiences with subcutaneous recombinant human hyaluronidase" JOURNAL OF PALLIATIVE MEDICINE, MARY ANN LIEBERT, US, vol. 10, no. 4, 1 August 2007 (2007-08-01), pages 861-864, XP009124656 ISSN: 1096-6218 (B1)
RIET CORREA P ET AL: "Potentialization of the action of insulin by hyaluronidase" ANNALES D'ENDOCRINOLOGIE, MASSON, PARIS, FR, vol. 23, 1 January 1962 (1962-01-01), pages 23-28, XP009124583 ISSN: 0003-4266 (B1)
VAUGHN DANIEL E ET AL: "Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase." DIABETES TECHNOLOGY & THERAPEUTICS JUN 2009, vol. 11, no. 6, June 2009 (2009-06), pages 345-352, XP002552070 ISSN: 1520-9156 (B1)
VOYER V ET AL: "Insulin therapy with alidase in multiple injections: Sacerodoti-Yagdjoglou method" UNION MEDICALE DU CANADA, MONTREAL, CA, vol. 86, no. 8, 1 August 1957 (1957-08-01), pages 861-865, XP009124580 ISSN: 0041-6959 (B1)
WO-A-2008/016729 (B1)
BOOKBINDER ET AL: "A recombinant human enzyme for enhanced interstitial transport of therapeutics" JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 114, no. 2, 28 August 2006 (2006-08-28), pages 230-241, XP005625403 ISSN: 0168-3659 (B1)
Statushistorie
| Hovedstatus | Beslutningsdato, detaljstatus |
|---|---|
| Patent opphørt | Ikke betalt årsavgift |
| EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
| EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
|
Dato
Type korrespondanse
Journal beskrivelse
|
|---|
|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
|
Utgående
EP Batch Påminnelse om ikke betalt årsavgift (3331)
|
|
Innkommende
EP Publiseringsdokument fra EPO
|
|
Utgående
EP Registreringsbrev (3210)
|
|
Innkommende, AR99266774
Søknadsskjema Patent
|
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
| Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
|---|---|---|---|---|
| Årsavgift 9. avg. år (EP) | 2017.04.19 | 2850 | CPA Global (Patrafee) AB | Betalt og godkjent |
| Årsavgift 8. avg. år (EP) | 2016.04.15 | 2550 | Patrafee AB | Betalt og godkjent |
| 31504282 expand_more expand_less | 2015.04.23 | 55700 | Bryn Aarflot AS | Betalt |
|
Valideringsavgift EP-patent tillegg >14 sider
54500 = 218 X 250
Valideringsavgift EP-patent
1200 = 1 X 1200
|
||||
| Årsavgift 7. avg. år (EP) | 2015.04.20 | 2200 | Patrafee AB | Betalt og godkjent |